Dataset opportunity
Sfm Medical — 监管记录数据集机会
Sfm Medical 持有的中等监管记录数据集，可用于监管 RAG 和合规性 Copilots。
Score
73.1
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
56%
Action
许可
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球监管科技市场 = 2025 年为 243 亿美元，复合年增长率为 21.1%。
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
监管记录数据集
Modality
文本
Sector
医疗保健
Volume
中等
Freshness
实时
Rarity
中等
Accessibility
部分
Legal
混合所有权 — 许可权待明确
Buyer persona
监管科技与合规 AI 供应商
Sfm Medical 持有全面的监管记录数据集，数据模式为文本，包含其制造运营的关键证据，如质量检查日志、工艺参数和其他监管文件。这些结构化和非结构化数据非常适合开发监管 RAG 系统，使 AI 能够准确检索和生成有关复杂合规性、质量保证和审计相关查询的答案。
该数据的商业价值体现在快速扩张的全球监管科技市场，该市场在 2025 年的估值为243 亿美元，预计将以21.1% 的复合年增长率增长。[1] 尽管合同制造模式和高度管制的环境带来了访问复杂性，但这种工业数据的稀有性和深度为寻求在此高增长领域构建强大、合规解决方案的 AI 买家提供了独特的竞争优势。⚠ 尽职调查（有价值的数据，可协商访问）：合同制造模式意味着部分数据所有权可能与医疗科技客户共享；高度管制的医疗环境需要严格遵守数据传输规定；数据包含敏感的制造工艺参数和质量检查日志。· 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据共同证明 Sfm Medical 拥有其医疗设备制造业务的深度专有监管文件库。该数据集是为医疗保健领域构建 AI 工具的监管科技供应商的首选收购目标，因为它直接支持开发复杂的监管 RAG 系统。在全球监管科技市场预计到 2025 年将达到 243 亿美元的背景下，这一独特的真实世界欧盟 MDR 合规性和质量管理文件集合为下一代合规模型的培训和验证提供了独特的竞争优势。
See dimension details ↓- Legal Accessibility56
开放/API 访问
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility66
中等难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength74
4 种证据类型，4 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License36
所有权=混合，许可=权利不明确
Whether the company can legally license the data out — based on ownership and licensing complexity. - Dataset Specificity90
主导“监管”，行业医疗保健，3 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity58
专有领域数据（开放降低稀有度）
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume58
4 次证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
实时/流式传输
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
适用于监管 RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
AI 买家需求极高，这得益于监管科技市场 21.1% 的快速复合年增长率，该市场需要高质量、特定领域的监管数据来开发先进的合规和风险管理解决方案。[1]
How strongly AI builders and companies are likely to want this data, based on market signals. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 数据胃口信号（0 类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit75
✓ 良好目标 — 良好目标：sfm 是一家独立的单次使用医疗设备 OEM/合同制造商，其核心业务的副产品产生的监管数据非常适合，尽管其规模对于中小企业来说偏大。问题：该公司在德国和捷克共和国拥有约 380 名员工，这使其处于中小企业定义的上限或略高于上限。[18]；存在多个名称相似但法律实体不同的公司（例如，SFM Hospital Products GmbH、SF Medical Products GmbH），需要精确定位。[4, 20
- Deep Qualification70
⚠ 需要审查 — Sfm Medical 是一家为医疗科技客户提供服务的合同制造商，因此产生的监管和质量数据是所提供服务的副产品。这强烈暗示数据归其客户所有，尽管数据与细分市场高度相关，但仍是收购的一个重大障碍。[数据归公司客户所有]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Downloads / exports
这些证据表明持有者拥有可下载的监管证书和授权库，对于培训模型识别和分类官方合规文件非常宝贵。
Industrial data
这指向来自生产线内质量控制系统的数据，直接将生产事件与工艺可靠性文件联系起来。
Regulatory records
这是拥有涵盖监管要求实施的高价值文件的直接证明，包括根据医疗器械法规 (MDR) 颁发的欧盟质量管理体系证书。
IoT / sensor data
这些证据概述了其工业流程的范围，包括灭菌等高度管制的活动，表明拥有广泛的相关运营和合规数据。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Sfm Medical Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global RegTech market = $24.3B in 2025, CAGR 21.1% (source: Grand View Research). Investment score 73.1/100 (confidence 0.56). Recommended action: License.
From the marketplace
Explore live data opportunities
Deutsche Pensexpert — 监管记录数据集机会
View opportunity →其他Reachexploration — 监管记录数据集机会
View opportunity →出行Fiege — 监管记录数据集机会
View opportunity →